{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:22Z","timestamp":1786728622615,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In Saudi Arabia, a diet for life policy has been adopted in the management of amino acid metabolism disorders for years. However, the specially designed low protein products\/medical foods - which are one of the important treatment tools - were not available up until several years ago in Saudi Arabia (SA). Our aim was to measure the compliance and quality of life in patients affected with these disorders followed in the metabolic nutrition clinic at King Faisal Specialist Hospital &amp; Research Centre (KFSH&amp;RC), Riyadh, SA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>We used a non-randomized retrospective\/prospective study which utilized the growth parameters, biochemical data of patients plus questionnaires collected from patients and their family\/ caregivers. A total of n = 182 patients affected with selected amino acid metabolism disorders were enrolled. Some were excluded n = 84 for various reasons. Sample analyzed were: Phenylketonuria (PKU) (44), Maple Syrup Urine Disease (MSUD) (30), Tyrosinemia (TYR) (17) and Homocystinuria (HCU) (7). Tandem Mass Spectrometry (TMS) used to quantitate plasma amino acid concentrations. Data was obtained using (COMPLE) Microsoft-Access which was designed by the metabolic nutrition clinic at KFSH&amp;RC-Riyadh. Student's paired t-test was used to investigate relationship between variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The main findings were the improvement of selected amino acid levels pre and post the usage of medical foods. In PKU patients, the TMS Phenylalanine (PHE) levels post usage was significantly decreased (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; .0001). This was also the case in MSUD patients with significant decrease in Leucine &amp; Isoleucine levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value .0008) but not in Valine levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value .1148) as 36.7% of them received Valine supplements while enrolled in the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Low protein products availability was successful in improving outcomes for selected amino acid metabolic disorders. However, due to compliance issues and impracticality of the diet, the results were not significant in all enrolled patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijpam.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T04:06:31Z","timestamp":1528949191000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients"],"prefix":"10.4103","volume":"5","author":[{"given":"Bedour","family":"Handoom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Megdad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Al-Qasabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munirah","family":"Al Mesned","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Hawary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Al-Nufiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair","family":"Al-Hassnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeenaldeen Dia","family":"Alsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmoneim","family":"Eldali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20240319","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmhg.2016.03.002","article-title":"Challenges identified in the management of patients with inherited metabolic disorders - a five year experience from Pakistan","volume":"17","author":"Afroze","year":"2016","journal-title":"Egypt J Med Human Genet"},{"key":"R3-5-20240319","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10545-005-4478-8","article-title":"Living with phenylketonuria: perspectives of patients and their families","volume":"28","author":"Bilginsoy","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"R4-5-20240319","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"R5-5-20240319","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-277X.2011.01199.x","article-title":"Weaning infants with phenylketonuria: a review","volume":"25","author":"MacDonald","year":"2011","journal-title":"J Hum Nutr Diet"},{"key":"R6-5-20240319","first-page":"36","article-title":"Effect of dietary regime on metabolic control in phenylketonuria: is exact calculation of phenylalanine intake really necessary?","volume":"5","author":"Rohde","year":"2015","journal-title":"Mol Genet Metabol Rep"},{"key":"R7-5-20240319","first-page":"43","article-title":"Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patient, caregiver and provider perspectives","volume":"8","author":"Shchelochkov","year":"2016","journal-title":"Mol Genet Metabol Rep"},{"key":"R8-5-20240319","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF01957759","article-title":"Psychological and social findings in adolescents with phenylketonuria","volume":"151","author":"Weglage","year":"1992","journal-title":"Eur J Pediatr"},{"key":"R9-5-20240319","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2015.12.007","article-title":"Metabolic Diet App Suite for inborn errors of amino acid metabolism","volume":"117","author":"Ho","year":"2016","journal-title":"Mol Genet Metabol"},{"key":"R10-5-20240319","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-277X.2012.01229.x","article-title":"Feeding difficulties in children with inherited metabolic disorders: a pilot study","volume":"25","author":"Evans","year":"2012","journal-title":"J Hum Nutr Diet"},{"key":"R11-5-20240319","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-277X.1997.00050.x","article-title":"Abnormal feeding behaviours in phenylketonuria","volume":"10","author":"MacDonald","year":"1997","journal-title":"J Hum Nutr Diet"},{"key":"R12-5-20240319","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2648.1998.00530.x","article-title":"Non-compliance and professional power","volume":"27","author":"Playle","year":"1998","journal-title":"J Adv Nurs"},{"key":"R13-5-20240319","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000342256","article-title":"Adherence issues in inherited metabolic disorders treated by low natural protein diets","volume":"61","author":"MacDonald","year":"2012","journal-title":"Ann Nutr Metabol"},{"key":"R14-5-20240319","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-5151(03)00091-4","article-title":"Adherence to long-term therapies: evidence for action","volume":"2","author":"De Geest","year":"2003","journal-title":"Eur J Cardiovasc Nurs"},{"key":"R16-5-20240319","first-page":"18","article-title":"Dietary treatment of destructive behavior associated with hyperphenylalaninemia","volume":"21","author":"Baumeister","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"R17-5-20240319","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/000456320103800502","article-title":"Assessment of adult phenylketonuria","volume":"38","author":"Cleary","year":"2001","journal-title":"Ann Clin Biochem"},{"key":"R18-5-20240319","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.ymgme.2011.07.015","article-title":"Neurological complications and behavioral problems in patients with phenylketonuria in a Follow-up Unit","volume":"104","author":"Gonz\u00e9lez","year":"2011","journal-title":"Mol Genet Metabol"},{"key":"R19-5-20240319","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/mgme.1999.2863","article-title":"Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria","volume":"67","author":"Koch","year":"1999","journal-title":"Mol Genet Metabol"},{"key":"R20-5-20240319","first-page":"1","article-title":"Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria","volume":"26","author":"Dobbelaere","year":"1","journal-title":"J Inherit Metab Dis 2003 Jul"},{"key":"R21-5-20240319","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10545-007-0549-3","article-title":"Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature","volume":"30","author":"Huemer","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"R22-5-20240319","first-page":"184","article-title":"Late diagnosed phenylketonuria patients Clinical presentation and results of treatment","volume":"6","author":"Pavone","year":"1993","journal-title":"Dev Brain Dysfunct"},{"key":"R23-5-20240319","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1651-2227.2009.01269.x","article-title":"Predicting health-related quality of life of parents of children with inherited metabolic diseases","volume":"98","author":"Hatzmann","year":"2009","journal-title":"Acta Paediatr"},{"key":"R24-5-20240319","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ymgme.2011.08.002","article-title":"Physical development in patients with phenylketonuria on dietary treatment: a retrospective study","volume":"104","author":"Belanger-Quintana","year":"2011","journal-title":"Mol Genet Metabol"},{"key":"R25-5-20240319","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ymgme.2011.08.023","article-title":"Nutrition in phenylketonuria","volume":"104","author":"MacDonald","year":"2011","journal-title":"Mol Genet Metabol"},{"key":"R26-5-20240319","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2013.179","article-title":"Recommendations for the nutrition management of phenylalanine hydroxylase deficiency","volume":"16","author":"Singh","year":"2014","journal-title":"Genet Med"},{"key":"R27-5-20240319","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0884533615586201","article-title":"Inherited metabolic disorders","volume":"30","author":"Boyer","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"R28-5-20240319","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jhn.12354","article-title":"The challenges of vitamin and mineral supplementation in children with inherited metabolic disorders: a prospective trial","volume":"29","author":"Daly","year":"2016","journal-title":"J Hum Nutr Diet"},{"key":"R29-5-20240319","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0148607181005005406","article-title":"Zinc and copper status of treated children with phenylketonuria","volume":"5","author":"Acosta","year":"1981","journal-title":"J Parenter Enteral Nutr"},{"key":"R30-5-20240319","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.dib.2015.07.026","article-title":"Micronutrient in hyperphenylalaninemia","volume":"4","author":"Crujeiras","year":"2015","journal-title":"Data Brief"},{"key":"R31-5-20240319","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10545-006-0108-3","article-title":"Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU)","volume":"29","author":"Hvas","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"R32-5-20240319","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1651-2227.1997.tb08587.x","article-title":"Effects of a low selenium state in patients with phenylketonuria","volume":"86","author":"Jochum","year":"1997","journal-title":"Acta Paediatr"},{"key":"R33-5-20240319","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00445606","article-title":"The selenium state of children","volume":"128","author":"Lombeck","year":"1978","journal-title":"Eur J Pediatr"},{"key":"R34-5-20240319","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3476(00)90022-2","article-title":"Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet","volume":"136","author":"Robinson","year":"2000","journal-title":"J Pediatr"},{"key":"R36-5-20240319","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.ymgme.2011.07.020","article-title":"Vitamin B12 deficiency and phenylketonuria","volume":"104","author":"Walter","year":"2011","journal-title":"Mol Genet Metabol"},{"key":"R37-5-20240319","first-page":"1167","article-title":"Saudi newborn screening","volume":"28","author":"Afifi","year":"2007","journal-title":"A national public health program: needs, costs, and challenges. Saudi Med J"},{"key":"R38-5-20240319","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jpc.13469","article-title":"Expanded newborn screening program in Saudi Arabia: incidence of screened disorders","volume":"53","author":"Alfadhel","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"R42-5-20240319","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/1475-3588.00031","article-title":"Psychological treatment of food refusal in young children","volume":"7","author":"Douglas","year":"2002","journal-title":"Child Adolesc Ment Health"},{"key":"R43-5-20240319","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2012.02.008","article-title":"Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases","volume":"106","author":"Cazzorla","year":"2012","journal-title":"Mol Genet Metabol"},{"key":"R44-5-20240319","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1651-2227.2011.02227.x","article-title":"Adherence to diet and quality of life in patients with phenylketonuria","volume":"100","author":"Cotugno","year":"2011","journal-title":"Acta Paediatr"},{"key":"R45-5-20240319","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0002-8223(03)00983-0","article-title":"Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy","volume":"103","author":"Acosta","year":"2003","journal-title":"J Am Diet Assoc"},{"key":"R46-5-20240319","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymgme.2012.07.006","article-title":"High prevalence of overweight and obesity in females with phenylketonuria","volume":"107","author":"Burrage","year":"2012","journal-title":"Mol Genet Metabol"},{"key":"R47-5-20240319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jhn.12054","article-title":"Body mass index in adult patients with diet-treated phenylketonuria","volume":"26","author":"Robertson","year":"2013","journal-title":"J Hum Nutr Diet"}],"container-title":["International Journal of Pediatrics and Adolescent Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352646718300322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352646718300322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01863514-201805020-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:27Z","timestamp":1786724967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01863514-201805020-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijpam.2018.04.001","relation":{},"ISSN":["2352-6467"],"issn-type":[{"value":"2352-6467","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pediatrics and Adolescent Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpam.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Publishing services provided by Elsevier B.V. on behalf of King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia.","name":"copyright","label":"Copyright"}]}}